Is Methylprednisolone Hydrogen Succinate Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use Methylprednisolone Hydrogen Succinate? Is Methylprednisolone Hydrogen Succinate safe for nursing mother and child? Does Methylprednisolone Hydrogen Succinate extracts into breast milk? Does Methylprednisolone Hydrogen Succinate has any long term or short term side effects on infants? Can Methylprednisolone Hydrogen Succinate influence milk supply or can Methylprednisolone Hydrogen Succinate decrease milk supply in lactating mothers?
Methylprednisolone Hydrogen Succinate lactation summary
- DrLact safety Score for Methylprednisolone Hydrogen Succinate is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of Methylprednisolone Hydrogen Succinate is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that Methylprednisolone Hydrogen Succinate does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of Methylprednisolone Hydrogen Succinate safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About Methylprednisolone Hydrogen Succinate usage in lactation
Excreted into breast milk in non-significant amount with no problems reported in breastfed infants whose mothers were treated at a daily dose as high as 8 mg for a long time period. On long term treatments it would be advisable to wait for 2 - 4 hours until the next nurse to minimize the transfer of drug to breast milk. By waiting for 2 a 4 hours after a methylprednisolone megadose or a pulse therapy dose, the transfer into breast milk may be minimized as well. At high doses, intra-articular treatment with other steroid drugs (Triamcinolone) have transiently affected milk production. Steroids administered before delivery may delay initiation of phase II of Lactogenesis ("milk come in") and decrease milk production in the first postpartum week. Decreased production has been seen while taking Dexametasone. Steroid drugs are commonly used for Pediatric treatment with no side effects when infrequently used and for short-time periods. The American Academy of Pediatrics rates it compatible with breastfeeding. WHO Model List of Essential Medicines (2002) rates it compatible with breastfeeding